Preparation and characterization of nanocochelate by using phosphatidylcholine as lipid carrier for enhancement of permeability and bioavailability of rosuvastatin

References

• Jasińska-Stroschein M, Owczarek J, Surowiecka A, et al. HMG-CoA reductase inhibitors: an opportunity for the improvement of imatinib safety. An experimental study in rat pulmonary hypertension. Pharmacol Rep. 2015;67(1):32–37.
   PubMedGoogle Scholar
• Ucak A, Onan B, Güler A, et al. Rosuvastatin, a new generation 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, reduces ischemia/reperfusion-induced spinal cord tissue injury in rats. Ann Vasc Surg. 2011;25(5):686–695.
   PubMedGoogle Scholar
• Abd-Elsalam WH, El-Helaly SN, Ahmed MA, et al. Preparation of novel phospholipid-based sonocomplexes for improved intestinal permeability of rosuvastatin: in vitro characterization, dynamic simulation, Caco-2 cell line permeation and in vivo assessment studies. Int J Pharm. 2018;548(1):375–384.
   PubMedGoogle Scholar
• Schachter M. Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update. Fundam Clin Pharmacol. 2005;19(1):117–125.
   PubMed Web of Science ®Google Scholar
• Tiwari R, Pathak K. Statins therapy: a review on conventional and novel formulation approaches. J Pharm Pharmacol. 2011;63(8):983–998.
   PubMed Web of Science ®Google Scholar
• Budha RR, Thaakur S, Rao GK, et al. Multidose studies in rabbits for determining pharmacokinetic and pharmacodynamic interactions of gliclazide with nutraceutical. Int J Pharm Sci Res. 2021;13(1):3876–3881.
   Google Scholar
• Y Karasulu H, Turgay T, Türk U, et al. Development and optimization of self-emulsifying drug delivery systems (SEDDS) for enhanced dissolution and permeability of rosuvastatin. Curr Drug Deliv. 2016;13(3):362–370.
   PubMedGoogle Scholar
• Bhosale RR, Gangadharappa HV, Gowda DV, et al. A review on nanocochleates: the inimitable nanoparticulate drug carriers. Adv Sci Engng Med. 2017;9(5):359–369.
   Google Scholar
• Zhong X, Chen B, Yang Z. Nanocochleates as the potential delivery systems for oral antitumor of hydroxycamptothecin. J Biomed Nanotechnol. 2018;14(7):1339–1346.
   PubMed Web of Science ®Google Scholar
• Yeole SE, Pimple SS, Chaudhari PD. A review on nanocochleate–a novel lipid based drug delivery system. J Biomed Pharm Res. 2013;2:1–7.
   Google Scholar
• Bothiraja C, Yojana BD, Pawar AP, et al. Fisetin-loaded nanocochleates: formulation, characterisation, in vitro anticancer testing, bioavailability and biodistribution study. Expert Opin Drug Deliv. 2014;11(1):17–29.
   PubMed Web of Science ®Google Scholar
• Tamargo B, Monzote L, Piñón A, et al. In vitro and in vivo evaluation of essential oil from Artemisia absinthium L. formulated in nanocochleates against cutaneous leishmaniasis. Medicines. 2017;4(2):38.
   Google Scholar
• Liu M, Zhong X, Yang Z. Chitosan functionalized nanocochleates for enhanced oral absorption of cyclosporine A. Sci. Rep. 2017;7(1):1–10.
   PubMedGoogle Scholar
• Yadav A, Chaudhari S. Formulation and characterization of nanocochelate for improvement of permeability of drug. J Adv Pharm Res. 2016;2016:16–23.
   Google Scholar
• Bothiraja C, Rajput N, Poudel I, et al. Development of novel biofunctionalized chitosan decorated nanocochleates as a cancer targeted drug delivery platform. Artif Cells Nanomed Biotechnol. 2018;46(sup1):447–461.
   PubMed Web of Science ®Google Scholar
• Asasutjarit R, Sorrachaitawatwong C, Tipchuwong N, et al. Effect of formulation compositions on particle size and zeta potential of diclofenac sodium-loaded chitosan nanoparticles. Int J Pharm Sci Drug Res. 2013;7(9):568–570.
   Google Scholar
• Mohan AC, Renjanadevi B. Preparation of zinc oxide nanoparticles and its characterization using scanning electron microscopy (SEM) and X-ray diffraction (XRD). Proc Technol. 2016;24:761–766.
   Google Scholar
• Attari Z, Bhandari A, Jagadish PC, et al. Enhanced ex vivo intestinal absorption of olmesartan medoxomil nanosuspension: preparation by combinative technology. Saudi Pharm J. 2016;24(1):57–63.
   PubMed Web of Science ®Google Scholar
• Liebermann HA, Martin MR, Gilbert S. Pharmaceutical dosage form disperse systems Vol. 2. New York: Marcel Dekker; 1989, p. 569–577.
   Google Scholar
• Kim BK, Hwang SJ, Park JB, et al. Preparation and characterization of drug-loaded polymethacrylate microspheres by an emulsion solvent evaporation method. J Microencapsul. 2002;19(6):811–822.
   PubMed Web of Science ®Google Scholar
• Asprea M, Leto I, Bergonzi MC, et al. Thyme essential oil loaded in nanocochleates: encapsulation efficiency, in vitro release study and antioxidant activity. LWT. 2017;77:497–502.
   Web of Science ®Google Scholar
• Tilawat M, Bonde S. Nanocochleates: a potential drug delivery system. J Mol Liq. 2021;334:116115.
   Google Scholar
• Manne R, Devarajan A. Development of nicotinic acid controlled release tablets with natural phenolic anti-oxidant polymer by encapsulation technique. J Nat Med. 2021;20(4):204–216.
   Google Scholar
• Berg JM, Romoser A, Banerjee N, et al. The relationship between pH and zeta potential of∼ 30 nm metal oxide nanoparticle suspensions relevant to in vitro toxicological evaluations. Nanotoxicology. 2009;3(4):276–283.
   Web of Science ®Google Scholar
• Du WL, Niu SS, Xu YL, et al. Antibacterial activity of chitosan tripolyphosphate nanoparticles loaded with various metal ions. Carbohydr Polym. 2009;75(3):385–389.
   Web of Science ®Google Scholar
• Khosravi-Darani K, Mozafari MR. Nanoliposome potentials in nanotherapy: a concise overview. J Nanosci Nanotechnol. 2010;6(1):3–13.
   Google Scholar
• Pawar A, Bothiraja C, Shaikh K, et al. An insight into cochleates, a potential drug delivery system. RSC Adv. 2015;5(99):81188–81202.
   Web of Science ®Google Scholar
• Pawar AP, Vinugala D, Bothiraja C. Nanocochleates derived from nanoliposomes for paclitaxel oral use: preparation, characterization, in vitro anticancer testing, bioavailability and biodistribution study in rats. Biomed Pharmacother. 2014;3502:1–9.
   Google Scholar
• Jain A, Kamble R, Patil S. Electrospray technology as a probe for single step fabrication of glipizide loaded nanocochleates with enhanced bioavailability. J Dispers Sci Technol. 2021;7:1–9.
   Google Scholar
• Nanjwade BK, Derkar GK, Bechra H, et al. Nanosized technological approaches for the delivery of poorly water soluble drugs. Iran J Pharm Sci. 2010;6(3):149–162.
   Google Scholar
• Pramanik S, Mohanto S, Manne R, et al. Nanoparticle-based drug delivery system: the magic bullet for the treatment of chronic pulmonary diseases. Mol Pharm. 2021;18(10):3671–3718.
   PubMedGoogle Scholar